Authors:
LINK KH
LEDER G
PILLASCH J
BUTZER U
STAIB L
KORNMANN M
BRUCKNER U
BEGER HG
Citation: Kh. Link et al., IN-VITRO CONCENTRATION RESPONSE STUDIES AND IN-VITRO PHASE-II TESTS AS THE EXPERIMENTAL BASIS FOR REGIONAL CHEMOTHERAPEUTIC PROTOCOLS, Seminars in surgical oncology, 14(3), 1998, pp. 189-201
Citation: M. Kornmann et al., ROLE OF FIBROBLAST GROWTH-FACTORS AND THEIR RECEPTORS IN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS, Pancreas, 17(2), 1998, pp. 169-175
Authors:
KORNMANN M
ISHIWATA T
ITAKURA J
TANGVORANUNTAKUL P
BEGER HG
KORC M
Citation: M. Kornmann et al., INCREASED CYCLIN D1 IN HUMAN PANCREATIC-CANCER IS ASSOCIATED WITH DECREASED POSTOPERATIVE SURVIVAL, Oncology, 55(4), 1998, pp. 363-369
Citation: M. Kornmann et al., INHIBITION OF BASAL AND MITOGEN-STIMULATED PANCREATIC-CANCER CELL-GROWTH BY CYCLIN D1 ANTISENSE IS ASSOCIATED WITH LOSS OF TUMORIGENICITY AND POTENTIATION OF CYTOTOXICITY TO CISPLATINUM, The Journal of clinical investigation, 101(2), 1998, pp. 344-352
Citation: T. Ishiwata et al., ENHANCED FIBROBLAST-GROWTH-FACTOR-5 EXPRESSION IN STROMAL AND EXOCRINE ELEMENTS OF THE PANCREAS IN CHRONIC-PANCREATITIS, Gut, 43(1), 1998, pp. 134-139
Authors:
KORNMANN M
MARUYAMA H
BERGMANN U
TANGVORANUNTAKUL P
BEGER HG
WHITE MF
KORC M
Citation: M. Kornmann et al., ENHANCED EXPRESSION OF THE INSULIN-RECEPTOR SUBSTRATE-2 DOCKING PROTEIN IN HUMAN PANCREATIC-CANCER, Cancer research, 58(19), 1998, pp. 4250-4254
Citation: M. Kornmann et al., FIBROBLAST GROWTH FACTOR-5 STIMULATES MITOGENIC SIGNALING AND IS OVEREXPRESSED IN HUMAN PANCREATIC-CANCER - EVIDENCE FOR AUTOCRINE AND PARACRINE ACTIONS, Oncogene, 15(12), 1997, pp. 1417-1424
Authors:
ISHIWATA T
BERGMANN U
KORNMANN M
LOPEZ M
BEGER HG
KORC M
Citation: T. Ishiwata et al., ALTERED EXPRESSION OF INSULIN-LIKE-GROWTH-FACTOR-II RECEPTOR IN HUMANPANCREATIC-CANCER, Pancreas, 15(4), 1997, pp. 367-373
Authors:
KORNMANN M
LINK KH
LENZ HJ
PILLASCH J
METZGER R
BUTZER U
LEDER GH
WEINDEL M
SAFI F
DANENBERG KD
BEGER HG
DANENBERG PV
Citation: M. Kornmann et al., THYMIDYLATE SYNTHASE IS A PREDICTOR FOR RESPONSE AND RESISTANCE IN HEPATIC-ARTERY INFUSION CHEMOTHERAPY, Cancer letters, 118(1), 1997, pp. 29-35
Authors:
LINK KH
KORNMANN M
LEDER GH
BUTZER U
PILLASCH J
STAIB L
GANSAUGE F
BEGER HG
Citation: Kh. Link et al., REGIONAL CHEMOTHERAPY DIRECTED BY INDIVIDUAL CHEMOSENSITIVITY TESTINGIA VITRO - A PROSPECTIVE DECISION-AIDING TRIAL, Clinical cancer research, 2(9), 1996, pp. 1469-1474
Authors:
BERGMANN U
FUNATOMI H
KORNMANN M
ISHIWATA T
BEGER HG
KORC M
Citation: U. Bergmann et al., INSULIN-LIKE GROWTH-FACTOR-II ACTIVATES MITOGENIC SIGNALING IN PANCREATIC-CANCER CELLS VIA IRS-1 - IN-VIVO EVIDENCE FOR AN ISLET-CANCER CELL AXIS, International journal of oncology, 9(3), 1996, pp. 487-492
Authors:
BERGMANN U
KORNMANN M
FUNATOMI H
BEGER H
KORC M
Citation: U. Bergmann et al., OVEREXPRESSION OF INSULIN-RECEPTOR SUBSTRATE-1 OCCURS FREQUENTLY IN HUMAN PANCREATIC CANCERS, Gastroenterology, 110(4), 1996, pp. 378-378
Authors:
BERGMANN U
FUNATOMI H
KORNMANN M
BEGER HG
KORC M
Citation: U. Bergmann et al., INCREASED EXPRESSION OF INSULIN-RECEPTOR SUBSTRATE-1 IN HUMAN PANCREATIC-CANCER, Biochemical and biophysical research communications, 220(3), 1996, pp. 886-890